Long-term docosahexaenoic acid therapy in a congenic murine model of cystic fibrosis
Satti Beharry(Hospital for Sick Children), Peter R. Durie(University of Toronto), Yew-Meng Heng, Imad Nasser(Beth Israel Deaconess Medical Center), Rhonda K. Yantiss(Memorial Sloan Kettering Cancer Center), Hilary Christensen, Munir M. Zaman, Catherine Luk, Mary Corey, Cameron Ackerley(University of Toronto), Geraldine Kent(Hospital for Sick Children), Steven D. Freedman(Beth Israel Deaconess Medical Center)
American Journal of Physiology-Gastrointestinal and Liver Physiology
November 9, 2006
Cited by 55
Related Papers
Effect of VX-770 in Persons with Cystic Fibrosis and the G551D- <i>CFTR</i> Mutation
|New England Journal of Medicine|2010|802
Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome
|New England Journal of Medicine|2019|663
Definitions of Pediatric Pancreatitis and Survey of Present Clinical Practices
|Journal of Pediatric Gastroenterology and Nutrition|2012|508